ChemInform Abstract: The Highly Potent and Selective Dipeptidyl Peptidase IV Inhibitors Bearing a Thienopyrimidine Scaffold Effectively Treat Type 2 Diabetes.

Cheminform(2011)

Cited 1|Views2
No score
Abstract
Novel thienopyrimidine analogues (IV) and (VI) of alogliptin demonstrate potent and selective DPP-IV inhibitory activity.
More
Translated text
Key words
thienopyrimidine scaffold,inhibitors,cheminform,diabetes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined